combination drug

HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...

South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...

Morgan Stanley Private Equity has acquired a South Korean dietary supplements maker Life & Bio Co., in its first Korean buyout deal in eight yea...

SK Shieldus Co. and One Store Co., two units of South Korea's SK Square Co., submitted their initial public offering applications on Thursday to rai...

South Korea’s SK Chemicals plans to invest more than 2 trillion won ($1.6 billion) in eco-friendly material and biopharmaceutical businesses.T...

New York-based Morgan Stanley Private Equity is slated to sell its entire stake in Jeonju Paper Corp., South Korea's top newsprint producer, and its...

South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...

South Korea’s biotechnology startup Voronoi Inc. is in talks with global biomedical companies on drug designs as it aims to expand the busines...

Singapore’s antitrust authority approved the integration of Korean Air Lines Co. and Asiana Airlines Inc., paving the way for South Korea&rsqu...

South Korea’s Samsung Engineering made inroads into Russia’s plant engineering and construction market with a 1 billion euro ($1.1 billi...

Materials, components and equipment makers drove South Korea's mergers and acquisitions market to a record high last year, with smaller deals involv...

Mirae Asset Global Investments Co.’s global equity-traded funds (ETFs) topped the 100 trillion won mark, for the first time in the South Korea...

CICC Capital, a private equity firm of China's largest investment bank China International Capital Corporation (CICC), will create funds with a comb...

South Korea's three major shipbuilders in 2021 have received their largest amount of orders in eight years, surpassing their targets by 45%, accordi...

Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...

South Korea’s HK inno.N Corp. has signed a 640 billion won ($540 million) contract to license out its technology for K-CAB, a gastroesophageal...

Hyundai Motor Co., South Korea’s top automaker, has reorganized its overseas units, reducing the number of business sectors to five from nine,...

South Korea’s Kakao Entertainment Corp. has bought the world’s top Asian fantasy web novel platform Wuxiaworld, based in the US, to expa...

MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...

Samsung Electronics Co., in a surprise move, has merged its mobile and consumer electronics businesses into a single unit, and replaced chief execut...

South Korean private equity firm STIC Investments Inc. said on Nov. 30 it will invest 1.1 trillion won ($843.1 million) to expand Korean elecfoil ...

South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...

MBK Partners is in talks to buy management rights of two e-commerce platforms listed on South Korea's Kosdaq market in a package deal, according to ...

South Korea's Halla Group, the parent company of automotive parts maker Mando Corp., will combine its two autonomous driving business units into a s...

Samsung Bioepis Co., a leading South Korean biopharmaceutical company, has received approval from the US Food and Drug Administration for its Byoovi...

A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...

South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...

The Korea Investment Corporation (KIC) on Tuesday replaced its infrastructure and real estate investment heads, in a senior management reshuffle fol...

South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...

South Korean house prices have risen more during the President Moon Jae-in administration than any other as the current government has focused more ...